Ovata Capital Management’s GeneDx Holdings WGS Stock Holding History

Ovata Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-94	Closed	-$10K	–	145
2022 Q1	$10K	Buy	+94	New	+$10.4K	﹤0.01%	105

Other funds holding WGS

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ovata Capital Management's WGS Position: Q2 2022 in Review

Ovata Capital Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 94 shares — an estimated $10K sold.

Ovata Capital Management first reported a position in WGS in Q1 2022 and held it in 1 quarter. The position peaked at $10K in Q1 2022. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

Ovata Capital Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
Ovata Capital Management sold 94 GeneDx Holdings shares in Q2 2022, an estimated $10K.
Ovata Capital Management first reported a position in GeneDx Holdings in Q1 2022 and held it in 1 quarter.
Ovata Capital Management's GeneDx Holdings position peaked at $10K in Q1 2022.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Ovata Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.